/PRNewswire/ Bexson Biomedical, Inc., a research-stage company developing therapies and delivery solutions for pain management, addiction and mental health.
29.03.2022 - CHICAGO and TORONTO, March 29, 2022 (GLOBE NEWSWIRE) - Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new .